ISSN: 2161-0460

Jornal da doença de Alzheimer e parkinsonismo

Acesso livre

Nosso grupo organiza mais de 3.000 Séries de conferências Eventos todos os anos nos EUA, Europa e outros países. Ásia com o apoio de mais 1.000 Sociedades e publica mais de 700 Acesso aberto Periódicos que contém mais de 50.000 personalidades eminentes, cientistas de renome como membros do conselho editorial.

Periódicos de acesso aberto ganhando mais leitores e citações
700 periódicos e 15 milhões de leitores Cada periódico está obtendo mais de 25.000 leitores

Indexado em
  • Índice Copérnico
  • Google Scholar
  • Sherpa Romeu
  • Abra o portão J
  • Genâmica JournalSeek
  • Chaves Acadêmicas
  • JornalTOCs
  • Infraestrutura Nacional de Conhecimento da China (CNKI)
  • Biblioteca de Periódicos Eletrônicos
  • RefSeek
  • Universidade Hamdard
  • EBSCO AZ
  • OCLC – WorldCat
  • Catálogo online SWB
  • Biblioteca Virtual de Biologia (vifabio)
  • Publons
  • Fundação de Genebra para Educação e Pesquisa Médica
  • Euro Pub
  • ICMJE
Compartilhe esta página

Abstrato

MIBG Cardiac Imaging is Less Promising in Differentiating PD from Other Parkinsonism for Early-Onset Patients

Wenjia Zhu, Dan Xu, Li Huo and Han Wang

Objective: Age at onset has an impact on cardiac meta-iodobenzylguanidine (MIBG) uptake in Parkinson’s disease (PD), but not in other parkinsonism. In the present study, we hypothesized that there is an interaction between age at onset and disease group for heart-to-mediastinum (H/M) ratios.

Methods: Ninety-two patients with parkinsonism, including 60 patients with PD and 32 patients with other neurodegenerative parkinsonism, were retrospectively reviewed. Patients were grouped into the early-onset group (age at onset ≤50 y/o) and late-onset group (age at onset >50 y/o) according to the time they first developed motor symptoms. 131I-MIBG cardiac scintigraphy was done and heart-to-mediastinum ratio was used to quantify cardiac uptake.

Results: There was a statistically significant interaction between disease group and age at onset for both early (P=0.008) and delayed H/M ratio (P=0.043). Subgroup analysis demonstrated that no significant difference was found between PD and other neurodegenerative parkinsonism in the early-onset group for either early (2.03 ± 0.42 vs. 2.01 ± 0.29, P=0.882) or delayed H/M ratio (2.05 ± 0.56 vs. 2.22 ± 0.52, P=0.468). In patients with PD, there was significant difference in H/M ratio for both early (P=0.004) and delayed scan (P=0.002) between early-onset and lateonset patients. In patients with other neurodegenerative parkinsonism, no significant difference was found in H/M ratio for either early (P=0.314) or delayed scan (P=0.902) between early-onset and late-onset patients. Using ROC analysis, H/M ratio can be used to differentiate PD from other neurodegenerative parkinsonism (AUC=0.749 and 0.784 for early and delayed scan, respectively). By deselecting early-onset patients, the discrimination power can be further improved (AUC=0.812 and 0.824 for early and delayed scan, respectively) in late-onset patients.

Conclusion: There is an interaction between age at onset and disease group for H/M ratios. 131I-MIBG cardiac sympathetic imaging is less promising in differentiating PD from other parkinsonism for early-onset patients.